X

Trial Profile

A Randomized, Controlled, Double-Masked Adaptive Design Evaluation of the Safety and Preliminary Efficacy of IVMED-85 on Pediatric Myopia

Status: Not yet recruiting

Phase of Trial: Phase I/II

Latest Information Update: 03 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs IVMED 85 (Primary)
Indications Degenerative myopia
Focus Adverse reactions; First in man; Therapeutic Use
Sponsors iVeena Delivery Systems

Most Recent Events

27 Sep 2023 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
27 Sep 2023 Planned primary completion date changed from 1 May 2025 to 1 May 2026.
27 Sep 2023 Planned initiation date changed from 1 May 2023 to 1 Feb 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com